Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Dougados

Showing results (421-430 of 600) with videos related to

Pageof 60
Sort By:
Rheumatology (Oxford, England)|April 3, 2019
Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once HLA-B27 status is known?Miranda van Lunteren, Désirée van der Heijde, Alexandre Sepriano, et al.
Clinical and Experimental Rheumatology|December 14, 2021
Elucidating the role of a positive family history in differentiating between axial and peripheral spondyloarthritis: an ancillary analysis of the ASAS-PerSpA studyYu Heng Kwan, Luanne Tan, Chuen Seng Tan, et al.
Joint Bone Spine|April 27, 2005
Structural evaluation in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinionLaure Gossec, Bruno Fautrel, Thao Pham, et al.
Arthritis and Rheumatism|July 30, 2005
Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trialJoel M Kremer, Maxime Dougados, Paul Emery, et al.
Annals of the Rheumatic Diseases|May 8, 2012
Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)Maxime Dougados, Karsten Kissel, Tom Sheeran, et al.
Arthritis and Rheumatism|June 28, 2006
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trialDésirée van der Heijde, Alan Kivitz, Michael H Schiff, et al.
Annals of the Rheumatic Diseases|September 15, 2011
Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST StudyMichael Schiff, Mauro Keiserman, Christine Codding, et al.
Arthritis Care & Research|February 13, 2013
Potential classification criteria for rheumatoid arthritis after two years: results from a French multicenter cohortAlain Saraux, Gabriel J Tobón, Mathilde Benhamou, et al.
Arthritis Research & Therapy|December 15, 2016
Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritisJérémie Sellam, Elodie Rivière, Alice Courties, et al.
Joint Bone Spine|October 14, 2018
Update of French society for rheumatology recommendations for managing rheumatoid arthritisClaire Daien, Charlotte Hua, Cécile Gaujoux-Viala, et al.
Pageof 60

Showing results (421-430 of 600) with videos related to

Sort By:
Pageof 60
Rheumatology (Oxford, England)|April 3, 2019
Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once HLA-B27 status is known?Miranda van Lunteren, Désirée van der Heijde, Alexandre Sepriano, et al.
Clinical and Experimental Rheumatology|December 14, 2021
Elucidating the role of a positive family history in differentiating between axial and peripheral spondyloarthritis: an ancillary analysis of the ASAS-PerSpA studyYu Heng Kwan, Luanne Tan, Chuen Seng Tan, et al.
Joint Bone Spine|April 27, 2005
Structural evaluation in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinionLaure Gossec, Bruno Fautrel, Thao Pham, et al.
Arthritis and Rheumatism|July 30, 2005
Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trialJoel M Kremer, Maxime Dougados, Paul Emery, et al.
Annals of the Rheumatic Diseases|May 8, 2012
Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)Maxime Dougados, Karsten Kissel, Tom Sheeran, et al.
Arthritis and Rheumatism|June 28, 2006
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trialDésirée van der Heijde, Alan Kivitz, Michael H Schiff, et al.
Annals of the Rheumatic Diseases|September 15, 2011
Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST StudyMichael Schiff, Mauro Keiserman, Christine Codding, et al.
Arthritis Care & Research|February 13, 2013
Potential classification criteria for rheumatoid arthritis after two years: results from a French multicenter cohortAlain Saraux, Gabriel J Tobón, Mathilde Benhamou, et al.
Arthritis Research & Therapy|December 15, 2016
Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritisJérémie Sellam, Elodie Rivière, Alice Courties, et al.
Joint Bone Spine|October 14, 2018
Update of French society for rheumatology recommendations for managing rheumatoid arthritisClaire Daien, Charlotte Hua, Cécile Gaujoux-Viala, et al.
Pageof 60